Therefore, the possibility of better responses of p16INK4A-positive cases in advanced FIGO stage to chemotherapy and radiation therapy, as observed in head and neck cancer cases27,29, cannot be excluded. The gene discussed is CDKN2A; the disease is head and neck cancer.